Related Experiment Videos
[Should antibiotic prevention be used in biliary tract surgery?]
Schweizerische Medizinische Wochenschrift
|April 16, 1983
Summary
Single-dose mezlocillin effectively prevents surgical site infections in biliary tract surgery patients. This antibiotic prophylaxis is recommended for all patients undergoing these procedures.
Area of Science:
- Surgical Infectious Disease
- Pharmacology
- Clinical Trials
Background:
- Biliary tract surgery carries a risk of infectious complications.
- Preventive antibiotic strategies are crucial for reducing surgical site infections.
Purpose of the Study:
- To evaluate the efficacy of a single prophylactic dose of mezlocillin in preventing infectious complications during biliary tract surgery.
Main Methods:
- A prospective, controlled, double-blind, randomized multicentre trial was conducted in Switzerland.
- Adult patients undergoing elective or emergency biliary tract surgery received either mezlocillin or a placebo during anesthesia induction.
Main Results:
- Single-dose mezlocillin significantly reduced the incidence of wound infections from 10% to 4%.
- No significant reduction was observed in other types of infectious complications.
- The baseline wound infection rate in the control group was notably lower than in international comparisons.
Conclusions:
- Prophylactic single-dose mezlocillin is justified for all patients undergoing biliary tract surgery.
- Predicting individual patient risk for infection to withhold prophylaxis is unreliable.